: Verified by RoundPaper
Verified NonprofitLast Filed 2024EIN 83-2886283
Advancing Cancer Treatment
MOULTONBOROUGH, NHNTEE: G12Founded 2018
MOULTONBOROUGH, NHNTEE: G12Founded 2018
Is this your organization?Claim your profile for free to personalize your presence and add a donate button. Learn more
Claiming and managing your profile is free. Enter any email you have access to. In the next step, we'll give you a small snippet to place on the organization's website to verify ownership.
We'll use this to process your claim and send important profile updates.
Need help? Contact us
MOULTONBOROUGH, NHNTEE: G12Founded 2018Website
mission statement
Acts mission is to make the washington, DC metropolitan area a leader in advancing clinical trial accrual, thus accelerating improved cancer care and treatment.
Share this profile
$10.6M raised across 5 grants (2019–2022 filings)
Funders across 1 states (2019–2022 filings)
| Funder | Total Awarded |
|---|---|
| Fidelity Investments Charitable Gift Fund | $10,600,000 |
Totals reflect grants as reported on funder tax returns. Timing may not match recipient revenue: funder and recipient fiscal years often differ, and grants paid by a funder in one year may be recognized by the recipient in a different year.
$786K in expenses
Vice President
Board Member
Board Member
President
Get a comprehensive Funder Intelligence Report with ranked prospects, fit scores, and funder briefs tailored to Advancing Cancer Treatment.
Edit your mission, add context to sections, and control what funders see.
Earn your verified badge